Response to selegiline (I-deprenyl) in senile dementia of Alzheimer type: relation to disease stage

Author： Klashka J.   Filip V.   David I.  

Publisher： Elsevier

ISSN： 0924-977X

Source： European Neuropsychopharmacology, Vol.5, Iss.3, 1995-09, pp. : 388-388

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Safety of Selegiline (Deprenyl) in the Treatment of Parkinson's Disease

By Heinonen E.H.  

Drug Safety, Vol. 19, Iss. 1, 1998-07 ,pp. : 11-22

Adis International

Access to resources Recommend Favorite

Metabolism of Selegiline [(-)-Deprenyl)]

By  

Current Medicinal Chemistry, Vol. 21, Iss. 13, 2014-04 ,pp. : 1522-1530

Bentham Science Publishers

Access to resources Recommend Favorite

Heterogeneity of anti-dementia drug response in Alzheimer type dementia

By Gavrilova S.I.   Seleznyova N.D.   Kolykhalov I.V.   Mikhailova N.M.   Roschina I.F.   Kalyn Y.B.   Zharikov G.A.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 386-386

Elsevier

Access to resources Recommend Favorite

Rivastigmine Transdermal Patch: In the Treatment of Dementia of the Alzheimer's Type

By Yang Lily P.H.   Keating Gillian M.  

CNS Drugs, Vol. 21, Iss. 11, 2007-01 ,pp. : 957-965

Adis International

Access to resources Recommend Favorite

Spotlight on Rivastigmine Transdermal Patch†: In Dementia of the Alzheimer's Type

By Dhillon Sohita  

Drugs & Aging, Vol. 28, Iss. 11, 2011-11 ,pp. : 927-930

Adis International

Access to resources Recommend Favorite